# SBC Medical Group Holdings Inc: financial statements, quarterly

SBC · Nasdaq · CIK 1930313 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sbc.md) · [Financials](/companies/sbc/financials.md) · [Filings](/companies/sbc/filings.md) · [Insiders](/companies/sbc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sbc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [47.3](/filings/0001493152-24-045154.md) | [62.3 d](/filings/0001641172-25-001062.md) | [54.8](/filings/0001641172-25-010567.md) | [53.1](/filings/0001641172-25-023322.md) | [53.1](/filings/0001193125-25-281466.md) | [44.4 d](/filings/0001193125-26-127557.md) | [47.3](/filings/0001193125-26-222737.md) | [43.4](/filings/0001193125-26-347843.md) | [43.4](/filings/0001193125-25-281466.md) | [39.6 d](/filings/0001193125-26-127557.md) | [43.1](/filings/0001193125-26-222737.md) | [49.2](/filings/0001193125-26-347843.md) |
| Cost of revenue | $m | [13.8](/filings/0001493152-24-045154.md) | [19.0 d](/filings/0001641172-25-001062.md) | [15.3](/filings/0001641172-25-010567.md) | [13.7](/filings/0001641172-25-023322.md) | [9.8](/filings/0001193125-25-281466.md) | [10.5 d](/filings/0001193125-26-127557.md) | [9.6](/filings/0001193125-26-222737.md) | [13.3](/filings/0001193125-26-347843.md) | [12.7](/filings/0001193125-25-281466.md) | [10.6 d](/filings/0001193125-26-127557.md) | [12.7](/filings/0001193125-26-222737.md) | [13.2](/filings/0001193125-26-347843.md) |
| Gross profit | $m | [33.5](/filings/0001493152-24-045154.md) | [43.4 d](/filings/0001641172-25-001062.md) | [39.5](/filings/0001641172-25-010567.md) | [39.4](/filings/0001641172-25-023322.md) | [43.2](/filings/0001193125-25-281466.md) | [33.9 d](/filings/0001193125-26-127557.md) | [37.7](/filings/0001193125-26-222737.md) | [30.0](/filings/0001193125-26-347843.md) | [30.6](/filings/0001193125-25-281466.md) | [28.9 d](/filings/0001193125-26-127557.md) | [30.3](/filings/0001193125-26-222737.md) | [36.0](/filings/0001193125-26-347843.md) |
| Selling, general and administrative | $m | [13.4](/filings/0001493152-24-045154.md) | [19.3 d](/filings/0001641172-25-001062.md) | [15.1](/filings/0001641172-25-010567.md) | [12.1](/filings/0001641172-25-023322.md) | [16.6](/filings/0001193125-25-281466.md) | [13.9 d](/filings/0001193125-26-127557.md) | [13.5](/filings/0001193125-26-222737.md) | [15.5](/filings/0001193125-26-347843.md) | [14.7](/filings/0001193125-25-281466.md) | [16.1 d](/filings/0001193125-26-127557.md) | [12.6](/filings/0001193125-26-222737.md) | [17.0](/filings/0001193125-26-347843.md) |
| Operating income | $m | [20.0](/filings/0001493152-24-045154.md) | [24.0 d](/filings/0001641172-25-001062.md) | [24.5](/filings/0001641172-25-010567.md) | [27.3](/filings/0001641172-25-023322.md) | [13.8](/filings/0001193125-25-281466.md) | [4.7 d](/filings/0001193125-26-127557.md) | [24.2](/filings/0001193125-26-222737.md) | [14.6](/filings/0001193125-26-347843.md) | [15.9](/filings/0001193125-25-281466.md) | [12.8 d](/filings/0001193125-26-127557.md) | [17.7](/filings/0001193125-26-222737.md) | [19.0](/filings/0001193125-26-347843.md) |
| Interest expense | $m | [0.0](/filings/0001493152-24-045154.md) | [0.0 d](/filings/0001641172-25-001062.md) | [0.0](/filings/0001641172-25-010567.md) | [0.0](/filings/0001641172-25-023322.md) | [0.0](/filings/0001193125-25-281466.md) | [0.0 d](/filings/0001193125-26-127557.md) | [0.0](/filings/0001193125-26-222737.md) | [0.0](/filings/0001193125-26-347843.md) | [0.0](/filings/0001193125-25-281466.md) | [0.1 d](/filings/0001193125-26-127557.md) | [0.1](/filings/0001193125-26-222737.md) | [0.1](/filings/0001193125-26-347843.md) |
| Income tax | $m | [13.0](/filings/0001493152-24-045154.md) | [9.3 d](/filings/0001641172-25-001062.md) | [8.5](/filings/0001641172-25-010567.md) | [8.5](/filings/0001641172-25-023322.md) | [10.3](/filings/0001193125-25-281466.md) | [(0.5) d](/filings/0001193125-26-127557.md) | [10.0](/filings/0001193125-26-222737.md) | [11.1](/filings/0001193125-26-347843.md) | [5.7](/filings/0001193125-25-281466.md) | [4.3 d](/filings/0001193125-26-127557.md) | [7.5](/filings/0001193125-26-222737.md) | [7.8](/filings/0001193125-26-347843.md) |
| Net income | $m | [8.4](/filings/0001493152-24-045154.md) | [14.3 d](/filings/0001641172-25-001062.md) | [18.8](/filings/0001641172-25-010567.md) | [18.5](/filings/0001641172-25-023322.md) | [2.8](/filings/0001193125-25-281466.md) | [6.5 d](/filings/0001193125-26-127557.md) | [21.5](/filings/0001193125-26-222737.md) | [2.5](/filings/0001193125-26-347843.md) | [12.8](/filings/0001193125-25-281466.md) | [14.2 d](/filings/0001193125-26-127557.md) | [11.3](/filings/0001193125-26-222737.md) | [10.7](/filings/0001193125-26-347843.md) |
| Diluted EPS | $ per share | [0.09](/filings/0001493152-24-045154.md) | not reported | [0.20](/filings/0001641172-25-010567.md) | [0.20](/filings/0001641172-25-023322.md) | [0.03](/filings/0001193125-25-281466.md) | not reported | [0.21](/filings/0001193125-26-222737.md) | [0.02](/filings/0001193125-26-347843.md) | [0.12](/filings/0001193125-25-281466.md) | not reported | [0.11](/filings/0001193125-26-222737.md) | [0.10](/filings/0001193125-26-347843.md) |
| Basic EPS | $ per share | [0.09](/filings/0001493152-24-045154.md) | not reported | [0.20](/filings/0001641172-25-010567.md) | [0.20](/filings/0001641172-25-023322.md) | [0.03](/filings/0001193125-25-281466.md) | not reported | [0.21](/filings/0001193125-26-222737.md) | [0.02](/filings/0001193125-26-347843.md) | [0.12](/filings/0001193125-25-281466.md) | not reported | [0.11](/filings/0001193125-26-222737.md) | [0.10](/filings/0001193125-26-347843.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.6](/filings/0001493152-23-040695.md) | [103](/filings/0001641172-25-001062.md) | [1.7](/filings/0001493152-24-020690.md) | [1.4](/filings/0001213900-24-070251.md) | [137](/filings/0001493152-24-045154.md) | [125](/filings/0001193125-26-127557.md) | [132](/filings/0001641172-25-010567.md) | [153](/filings/0001641172-25-023322.md) | [127](/filings/0001193125-25-281466.md) | [164](/filings/0001193125-26-347843.md) | [167](/filings/0001193125-26-222737.md) | [184](/filings/0001193125-26-347843.md) |
| Current assets | $m | [0.7](/filings/0001493152-23-040695.md) | [166](/filings/0001641172-25-001062.md) | [1.8](/filings/0001493152-24-020690.md) | [1.4](/filings/0001213900-24-070251.md) | [202](/filings/0001493152-24-045154.md) | [184](/filings/0001193125-26-127557.md) | [215](/filings/0001641172-25-010567.md) | [241](/filings/0001641172-25-023322.md) | [227](/filings/0001193125-25-281466.md) | [231](/filings/0001193125-26-347843.md) | [239](/filings/0001193125-26-222737.md) | [259](/filings/0001193125-26-347843.md) |
| Total assets | $m | [21.4](/filings/0001493152-23-040695.md) | [259](/filings/0001641172-25-001062.md) | [19.8](/filings/0001493152-24-020690.md) | [19.5](/filings/0001213900-24-070251.md) | [296](/filings/0001493152-24-045154.md) | [266](/filings/0001193125-26-127557.md) | [285](/filings/0001641172-25-010567.md) | [315](/filings/0001641172-25-023322.md) | [321](/filings/0001193125-25-281466.md) | [380](/filings/0001193125-26-347843.md) | [388](/filings/0001193125-26-222737.md) | [407](/filings/0001193125-26-347843.md) |
| Current liabilities | $m | [2.4](/filings/0001493152-23-040695.md) | [92.5](/filings/0001641172-25-001062.md) | [4.4](/filings/0001493152-24-020690.md) | [4.5](/filings/0001213900-24-070251.md) | [72.4](/filings/0001493152-24-045154.md) | [61.2](/filings/0001193125-26-127557.md) | [48.5](/filings/0001641172-25-010567.md) | [60.7](/filings/0001641172-25-023322.md) | [44.6](/filings/0001193125-25-281466.md) | [61.1](/filings/0001193125-26-347843.md) | [62.6](/filings/0001193125-26-222737.md) | [78.5](/filings/0001193125-26-347843.md) |
| Total liabilities | $m | [6.5](/filings/0001493152-23-040695.md) | [115](/filings/0001641172-25-001062.md) | [8.4](/filings/0001493152-24-020690.md) | [8.5](/filings/0001213900-24-070251.md) | [91.0](/filings/0001493152-24-045154.md) | [71.1](/filings/0001193125-26-127557.md) | [58.3](/filings/0001641172-25-010567.md) | [70.6](/filings/0001641172-25-023322.md) | [73.3](/filings/0001193125-25-281466.md) | [117](/filings/0001193125-26-347843.md) | [118](/filings/0001193125-26-222737.md) | [127](/filings/0001193125-26-347843.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [0.8](/filings/0001493152-24-045154.md) | [6.6](/filings/0001641172-25-001062.md) | [6.9](/filings/0001641172-25-010567.md) | [7.1](/filings/0001641172-25-023322.md) | [21.1](/filings/0001193125-25-281466.md) | [42.8](/filings/0001193125-26-127557.md) | [40.4](/filings/0001193125-26-222737.md) | [37.8](/filings/0001193125-26-347843.md) |
| Current portion of debt | $m | not reported | [0.3](/filings/0001641172-25-001062.md) | not reported | not reported | not reported | [0.3](/filings/0001193125-26-127557.md) | [0.3](/filings/0001641172-25-010567.md) | [0.3](/filings/0001641172-25-023322.md) | [0.3](/filings/0001193125-25-281466.md) | [0.2](/filings/0001193125-26-347843.md) | [0.2](/filings/0001193125-26-222737.md) | [0.2](/filings/0001193125-26-347843.md) |
| Short-term borrowings | $m | not reported | [1.0](/filings/0001493152-24-020690.md) | [2.7](/filings/0001493152-24-020690.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(5.6)](/filings/0001493152-23-040695.md) | [144](/filings/0001493152-24-045154.md) | [9.0](/filings/0001213900-24-070251.md) | [8.8](/filings/0001213900-24-070251.md) | [205](/filings/0001493152-24-045154.md) | [195](/filings/0001193125-26-127557.md) | [226](/filings/0001641172-25-010567.md) | [245](/filings/0001641172-25-023322.md) | [248](/filings/0001193125-25-281466.md) | [248](/filings/0001193125-26-347843.md) | [255](/filings/0001193125-26-222737.md) | [264](/filings/0001193125-26-347843.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [24.1 d](/filings/0001493152-24-045154.md) | [27.9 d](/filings/0001641172-25-001062.md) | [3.7](/filings/0001641172-25-010567.md) | [19.2 d](/filings/0001641172-25-023322.md) | [5.0 d](/filings/0001193125-25-281466.md) | [(7.3) d](/filings/0001193125-26-127557.md) | [1.9](/filings/0001193125-26-222737.md) | [(8.3) d](/filings/0001193125-26-347843.md) | [(20.9) d](/filings/0001193125-25-281466.md) | [52.0 d](/filings/0001193125-26-127557.md) | [9.2](/filings/0001193125-26-222737.md) | [22.5 d](/filings/0001193125-26-347843.md) |
| Capital expenditure | $m | not reported | [6.2 d](/filings/0001641172-25-001062.md) | [0.7](/filings/0001641172-25-010567.md) | [0.9 d](/filings/0001641172-25-023322.md) | [0.4 d](/filings/0001193125-25-281466.md) | [0.6 d](/filings/0001193125-26-127557.md) | [0.3](/filings/0001193125-26-222737.md) | [0.3 d](/filings/0001193125-26-347843.md) | [0.0 d](/filings/0001193125-25-281466.md) | [0.8 d](/filings/0001193125-26-127557.md) | [0.1](/filings/0001193125-26-222737.md) | [0.1 d](/filings/0001193125-26-347843.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001193125-26-127557.md) | not reported | not reported | [2.6 d](/filings/0001193125-25-281466.md) | [0.0 d](/filings/0001193125-26-127557.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [94.2](/filings/0001493152-24-045154.md) | [94.2](/filings/0001641172-25-010567.md) | [94.2](/filings/0001641172-25-023322.md) | [95.1](/filings/0001193125-25-281466.md) | [103](/filings/0001193125-26-222737.md) | [104](/filings/0001193125-26-347843.md) | [103](/filings/0001193125-25-281466.md) | [103](/filings/0001193125-26-222737.md) | [103](/filings/0001193125-26-347843.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 102,846,943 at 2026-07-31, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-347843.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.